Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Casein kinase 2 (CK2) is a kinase with many targets and diverse roles in cell signaling and disease.1,2 TBCA is a selective, cell-permeable inhibitor of CK2 (IC50 = 0.11 µM, Ki = 77 nM) that has minimal effect on a panel of 28 other kinases.3 It induces cell death in Jurkat adult T cell leukemia cells (DC50 = 7.7 µM), driving caspase-dependent degradation of poly-ADP ribose polymerase while inhibiting CK2 activity.3 TBCA also supports a role for CK2 in platelet function and Akt phosphorylation but not protein splicing.4,5
WARNING This product is not for human or veterinary use.
1. New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights. The FASEB Journal 24(9), 3171-3185 (2010).
2. Protein kinase CK2: A newcomer in the 'druggable kinome'. Biochem. Soc. Trans. 34(Pt 6), 1303-1306 (2006).
3. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem 8(1), 129-139 (2007).
4. Evaluation of CK2 inhibitor (E)-
5. Identification of a novel function of CX-